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Current imaging modalities to visualize vulnerability
within the atherosclerotic carotid plaque
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Jan-Luuk Hillebrands, PhD,c Riemer H.J.A. Slart, MD, PhD,d and Clark J. Zeebregts, MD, PhD,a
Groningen, The Netherlands
Background: There is increasing evidence that plaque vulnerability, rather than the degree of stenosis, is important in
predicting the occurrence of subsequent cerebral ischemic events in patients with carotid artery stenosis. The many
imaging modalities currently available have different properties with regard to the visualization of the extent of
vulnerability in carotid plaque formation.
Methods: Original published studies were identified using the MEDLINE database (January 1966 to March 2008).
Manual cross-referencing was also performed.
Results: There is no single imaging modality that can produce definitive information about the state of vulnerability of an
atherosclerotic plaque. Each has its own specific drawbacks, which may be the use of ionizing radiation or nephrotoxic
contrast agents, an invasive character, low patient tolerability, or simply the paucity of information obtained on plaque
vulnerability. Functional molecular imaging techniques such as positron emission tomography (PET), single photon
emission-computed tomography (SPECT) and near infra-red spectroscopy (NIRS) do seem able accurately to visualize
and even quantify features of plaque vulnerability and its pathophysiologic processes. Promising new techniques like near
infra-red fluorescence imaging are being developed and may be beneficial in this field.
Conclusion: There is a promising role for functional molecular imaging modalities like PET, SPECT, or NIRS related to
improvement of selection criteria for carotid intervention, especially when combined with CT or MRI to add further
anatomical details to molecular information. Further information will be needed to define whether and where this
functional molecular imaging will fit into a clinical strategy. (J Vasc Surg 2008;48:1620-9.)The current indication for intervention in patients with
carotid artery stenosis is primarily based on the degree of
stenosis and the symptoms.1,2 In contrast, it has become
apparent that coronary atherosclerosis produces symptoms
because of plaque rupture and this risk is determined more
by plaque composition than plaque size or degree of steno-
sis.3 The discrepancy in absolute risk reduction after carotid
endarterectomy (CEA) in symptomatic and asymptomatic
patients highlights the importance of factors other than
plaque size and degree of luminal obstruction in determin-
ing risk.4 Acute plaque rupture with subsequent thrombo-
sis may occur in vulnerable plaques that do not physically
appear threatening, whereas other lesions that are more
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1620flow-limiting may be dormant and not progress. The vul-
nerability is largely dictated by plaque morphology, which,
in turn, is influenced by pathophysiologic mechanisms at
the cellular and molecular level. Additionally, there is a
growing notion that plaque instability is important in the
etiology of acute cerebral ischemic events in patients with
carotid disease.5,6 Therefore, in the future patients may be
selected for intervention on the basis plaque vulnerability
assessed from morphologic characteristics, rather than on
the degree of stenosis or the symptoms.
PLAQUE MORPHOLOGY
There are various stages of atherosclerotic plaque de-
velopment, each with specific histopathologic characteris-
tics. In the mature stage, the plaque has advanced into an
occlusive atherosclerotic plaque characterized by smooth
muscle cell migration and the formation of a fibrous cap, a
lipid-rich necrotic core, and an ever-increasing inflamma-
tory infiltrate. Atherosclerotic plaque rupture associated
with inflammation has been correlated with the presence of
highly activated macrophages.7 Macrophages weaken the
extracellular matrix of the fibrous cap through phagocytosis
or by secreted proteolytic enzymes, such as cathepsins or
matrix metalloproteinases (MMPs), leading to plaque rup-
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 6 Wallis de Vries et al 1621ture.8 This exposes highly pro-thromboticmaterial, leading
to the formation of thrombus, which may result in clinically
recognizable events. In this review, we categorize the im-
aging techniques currently available and discuss specific
properties of each technique with regard to visualization
and quantification of vulnerability in carotid plaque forma-
tion. New developments within this field are also discussed.
CONVENTIONAL IMAGING TECHNIQUES
Angiography. In the North American Symptomatic
Carotid Endarterectomy Trial (NASCET) and European
Carotid Surgery Trial (ECST) trials, angiography was the
gold standard in determining luminal stenosis in carotid
extracranial disease.1,2 On the basis of these two trials
stenosis became the most important factor in defining
stroke risk. However, additional subset analysis of the
NASCET data showed that in 659 patients with stenosis
ranging from 70-99%, the risk of stroke increased between
70% and 94% and then actually decreased as occlusion was
approached.9 Other indicators than stenosis alone are
thought to be predictive of stroke risk. Already in 1978 it
wasmentioned byMoore, et al, that the aspect of ulceration
as detected on angiography could predict patients at high
risk for a subsequent stroke.10 Although in general, the
inter- and intra-observer variability in judging angiographic
images is small, the sensitivity and specificity of angiogra-
phy in detecting ulcerated plaques are less well-defined.6,11
Many studies compare the angiographic image with the
macroscopic appearance of the plaque, but not with histo-
logical findings. Therefore, the first 500 patients recruited
into NASCET underwent angiography in an attempt to
detect ulceration; angiography was subsequently compared
to observations during endarterectomy. Sensitivity and
specificity of detecting ulcerated plaques using angiography
were 46% and 74%, respectively. The positive predictive
value of identifying an ulcer was 72%. These results re-
mained unchanged with differing degrees of carotid steno-
sis and were confirmed by analyses based on receiver oper-
ating characteristic methodology.12 A comparable study
design was used for 1671 patients enrolled in ECST; sen-
sitivity and specificity for ulceration were 69% and 47%,
respectively.6 In studies where the radiological appearance
was compared to histology of the resected plaque, sensitiv-
ity ranged from 44% to 86%, and specificity from 33% to
74%, indicating that results vary extensively.13-15 Further-
more, the two largest studies comparing angiographic find-
ings to histology showed conflicting results.14,15 In the first
study, a series of 55 resected plaques from both symptom-
atic and asymptomatic patients was analyzed; no significant
correlation was found between angiography and histology
(P  .410).14 The second study examined 128 resected
plaques from symptomatic patients and compared angio-
graphic assessments to histologic features of the plaque,
using reproducible semi-quantitative scales. Angiographic
ulceration was associated with plaque rupture (P  .001),
intra-plaque hemorrhage (P  .001), large lipid core (P 
.005), less fibrous tissue (P  .003), and increased general
instability (P  .001). In comparisons between irregularand smooth plaques, a significant but less strong correla-
tion was found.15
There are conflicting results for detecting ulceration on
angiography. Eliasziw, et al, found that the presence of
angiographically defined ulceration is associated with an
increased risk of stroke,11 while Kim, et al, found no
significant relationship between angiographic ulceration
and neurological symptoms.14
It may be concluded that ulceration is the only marker
that can be detected on angiography, and with a very wide
range of sensitivity and specificity. There is little agreement
between angiography and histologic observation. The clin-
ical implication of ulceration as a marker has conflicting
results. Therefore, plaque morphology assessed by angiog-
raphy cannot determine accurately which carotid plaque is
stable and which is vulnerable.
Ultrasound (US). Since the 1980s, duplex ultra-
sonography has been widely used, mainly to measure flow
velocity and flow ratios. The severity of stenosis can be
determined by combining results of peak systolic velocity
(PSV), end-diastolic velocity (EDV) and pre- and post-
stenotic ratios.16 In a recent meta-analysis, duplex ultra-
sonography scan was found to have a sensitivity of 89% and
a specificity of 84% in detecting a stenosis degree of 70% to
99% in carotid arteries. The accuracy of detecting a stenosis
degree of 50% to 69%was considerably less (sensitivity 36%,
specificity 91%).17
In addition to flow measurements, echogenicity of
different parts of the artery wall and the atherosclerotic
plaque can be visualized. Areas with different shades of gray
provide information on plaque consistency. Originally, the
appearance of a plaque was either classified as echogenic
(calcified) or echolucent (non-calcified).18,19 Later, in an
attempt to decrease observer variability, more detailed clas-
sifications were developed, such as the ones proposed by
Gray-Weale and Geroulakos.20,21 In these studies, grading
of plaque morphology was largely based on the ultrasound
scan gray scale appearance, which was assessed subjectively
by visual inspection of ultrasound scan images. However,
these classifications showed a rather weak inter-investigator
reliability and little or no agreement with the histologic
results.22 An alternative approach to objectifying the
plaque’s structural composition is to quantify its echoge-
nicity by computer-assisted image analysis. There are sev-
eral possibilities for analyzing images, such as Gray Scale
Median (GSM), Pixel Distribution Analysis (PDA), and
Virtual Histology (VH).
Gray Scale Median (GSM) values are calculated by
digitizing B-mode images and subsequently processing
them with Adobe Photoshop (Adobe Systems Inc, San Jose,
Calif). Intraluminal blood and the adventitia are chosen as
reference points. The image is normalized by adjusting the
gray scale values of the image’s pixels according to the input
and output values of the two reference points. The GSM can
be used to quantify the echogenicity of the ultrasound scan
image and has been found to be a reproducible index of the
echogenicity of carotid plaques with low inter-observer and
inter-scanner variability (Fig 1).23,24
ian of
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tire plaque, PDA provides a mapping of individual tissue
components in the carotid plaque image. As with GSM,
PDA digitizes ultrasound scan images and normalizes the
pixel intensities between two constant reference points
(blood and arterial adventitia). By comparing maps of pixel
intensity with histology, one can determine Gray-Scale
Pixel Ranges for different types of tissue. Since pixel inten-
sity correlates with tissue type, one can use the computer to
apply a false color scale, creating a form of VH.25,26
Although recent advances in ultrasonographic evalua-
tion of plaques are promising, different ultrasound scan
studies have varied widely in both sensitivity and specificity
for determining surface ulceration.13,18,19,27,28 The same
applies to the detection of intra-plaque hemorrhage. More-
over, in up to 37% of cases, it is not possible to evaluate
the plaque surface due to acoustic shadowingor a high degree
of stenosis.29,30With the development of computer-assisted
image analysis, inter-observer variability of ultrasound scan
analysis has decreased. The Imaging in Carotid Angioplasty
and Risk of Stroke (ICAROS) trial showed that increased
echolucency of the carotid plaque, defined as a GSM of less
than 25, is a risk factor for stroke during and immediately
after carotid artery stenting. As the ICAROS trial recruited
patients receiving a carotid stent, there was no histologic
substrate to compare to the GSM.31 Denzel, et al, com-
pared B-mode images of 107 carotid endarterectomy spec-
imens and their GSM values to a histologic classification
consisting of only three groups (calcium-rich, lipid-rich,
and combined plaques). Only 46% of the cases showed
agreement between the GSM and the histopathologic find-
ings.30 Correlation of PDA with histology showed similar
results.25,32,33 Currently, it seems that the ability of ultra-
Fig 1. In-vivo B-mode image of a 70-99% symptomati
gray scale distribution (inlay) showed a Gray Scale Medsound scan to predict signs of vulnerability in the preoper-ative phase is limited. New computer-assisted image analy-
sis software is being introduced that should improve this
technique’s accuracy.
Intravascular ultrasound (IVUS). In addition to be-
ing used transcutaneously, the ultrasound scan technique
can be applied using miniature transducers small enough to
be placed within an angiographic catheter, achieving real-
time imaging of vascular structures.34 With IVUS, the high
frequency transducer (20 to 40 MHz) can be placed in
proximity to the tissue to be visualized, yielding images of
high spatial resolution. This makes it possible to assess the
vascular wall from within the lumen and to monitor blood
flow as well. Currently, IVUS is used as an integrated
monitoring tool in several vascular centers during en-
dograft and stent-graft placement, often to provide addi-
tional information on vessel wall morphology in order to
achieve optimal stent placement (Fig 2).35,36
So far, most of the work done on IVUS comes from the
field of coronary heart disease.32-34,37 An IVUS was first
described almost 20 years ago in the imaging of coronary
arteries.38 In coronary artery plaques, spectrum analysis of
IVUS-derived data has identified four major plaque com-
ponents, ie, fibrous, fibrofatty, necrotic core, and dense
calcified tissue.37 Recently, Irshad, et al, published their
early experiences with VH-IVUS during carotid artery
stenting. Five cases were presented in which VH-IVUS was
found to give useful plaque mapping.35 The Carotid Artery
Plaque Virtual Histology Evaluation (CAPITAL) study
analyzed the use of VH-IVUS in 15 patients who subse-
quently underwent carotid endarterectomy.39 The VH-
IVUS data were compared to histology of the resected
specimens. The diagnostic accuracy varied with the compo-
sition of the plaque (from 99% in thin-cap fibroatheroma to
tid stenosis in an 80-year-old male patient. Calculated
36.c caro72% for calcified atheroma). A drawback of IVUS is its
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patients had debris collected from their filters, presumably
due to manipulation of the IVUS probe.39 Further studies
will be needed to determine its definitive role during ca-
rotid artery stenting (CAS) and other vascular interven-
tions.35
Computed tomography (CT). A CT-angiography
(CTA) is a validated tool for determining the degree of
stenosis in the internal carotid artery. Single-slice CTA has
been shown to have a sensitivity of 79-87% and a specificity
of 88-90% (compared to “gold standard” angiography).40
A more recent study showed a significant correlation be-
tween single-slice CTA and angiography regarding degree
of carotid stenosis, with 100% sensitivity and 100% speci-
ficity using CTA to depict internal carotid artery (ICA)
stenosis greater than 70%.41
Assessment of arterial wall morphology with CTA is
clearly not as reliable as assessment of luminal narrowing.
Research has focused on three major topics, ie, ulceration,
calcification, and morphology/plaque composition. With
regard to detection of ulceration, somewhat disappointing
results have been found: sensitivity ranged between 50-94%
and specificity between 74-99%. Two studies compared
preoperative CTA images to postoperative histology.42,43
In both studies, a single-slice scanner was used, which
might explain the poor results. Saba, et al, used a multi-slice
CT with much better results. However, they did not use
histology as control, but instead examined the macroscopic
morphology of the plaque for ulceration.44
There are conflicting results in the detection of calcifi-
cation with CT. A comparison between CT images and
histology with regard to the amount of calcification is often
biased through decalcification in the processing of the
specimen for histology.42,43 Other explanations for the
conflicting results are displacement of calcified foci during
slide preparation, the inability to detect early stages of
mineralization microscopically, or the varying volume in-
corporated within the CT sections.42 Most studies have
shown that CT has a significant ability to detect calcifica-
tion.45-47 Some studies showed a relationship between
calcification and symptomatology,47 while others did
Fig 2. Virtual histology intravascular ultrasound (VH
with white calcium and green fibrous plaque (with kind
Scotland, UK).not.48It seems that calcification is the only histological con-
tent that can be determined in carotid plaques using CTA.
There have been some small studies illustrating the ability
of CT to determine plaque morphology.
In 2008, Wintermark, et al, published their results of
high-resolution CT imaging of carotid plaques, using a
multidetector-row CT (MDCT) and compared the images
with histology of the resected carotid plaques. Their study
population contained 8 patients and they found an overall
agreement of 72.6% between CTA and histologic examina-
tion. For large calcifications, CTA classified the lesions with
a 100% sensitivity and a 100% specificity. However, a sig-
nificant overlap between densities associated with lipid-rich
necrotic core, connective tissue, and hemorrhage limited
the reliability of individual pixel readings to identify these
components. Lipid cores were identified with a sensitivity
of 76% and a specificity of 74%, wide hemorrhages with a
sensitivity of 62% and a specificity of 99%, and ulcerations
with a sensitivity of 87% and a specificity of 99%.49
Hardie, et al, found, using MDCT, that expansive
carotid remodeling was significantly greater in patients with
cerebral ischemic symptoms than in asymptomatic patients.
The extent of expansive remodeling may indicate underly-
ing atherosclerotic plaque vulnerability.50 Saba, et al, found
a similar correlation between thickness of the arterial wall
and symptoms. The drawback to these studies is lack of
histologic confirmation of the CT images.51 A smaller
study (n 9) used CTA to assess plaque density; histologic
findings (lipid/hemorrhage, fibrous tissue) were reflected
in CTA findings.42 The two largest studies (n 38 and n
55) with histological confirmation purported that CTA
could not depict plaque morphology (lipid, hemorrhage,
fibrous tissue, inflammation).43,45 A recent study of 14
patients using a multi-slice scanner showed that CTA is
capable of characterizing and quantifying plaque burden,
calcifications, and fibrous tissue in atherosclerotic carotid
plaque, with results that correlated well with histology. The
study also had a good inter-observer reliability. However,
the lipid core could only be adequately quantified in certain
subsets of plaques, and hemorrhage and thrombus could
S) on a carotid stenosis, showing a calcified narrowing
ission of Donald B. Reid, MD, FRCS, WishawHospital,-IVU
permnot reliably be distinguished from lipid.52
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vulnerable plaques because it only visualizes the amount of
calcification, nor does it have the potential to provide
functional pathophysiologic information.
Magnetic resonance imaging (MRI). AnMRI’s abil-
ity to detect features of plaque vulnerability can be catego-
rized into intra-plaque hemorrhage, necrotic core, fibrous
cap, and calcification. Intra-plaque hemorrhage can be
detected with a sensitivity of 82-92% and a specificity of
74-100%.53-56 In addition, MRI can differentiate between
hemorrhages of different ages, but with only moderate
agreement betweenMRI and histology (  0.44-0.66).54
Moody, et al, showed that anMRI technique exploiting the
T1-shortening properties of recent thrombus can identify
histologically-confirmed carotid thrombus, and, thus,
complicated plaque.57 This technique has the advantage of
a short scan time of little over 4 minutes.
A lipid-rich necrotic core can be detected with MRI
with a sensitivity of 84-98% and a specificity of 65-
100%.53,55,56,58,59 More recently, in an ex-vivo experi-
ment, pixels were classified into different plaque compo-
nents and then compared to histological specimens.58
Necrotic core could be detected with a sensitivity of 84%
and a specificity of 75%. An in-vivo study showed that MRI
measurements of the lipid-rich necrotic core did not differ
significantly from findings on histologic examination of the
resected carotid plaque with a strong correlation between
MRI and histologic area measurements (r  0.75; P 
.001).55 Gadolinium-enhanced images showed even better
results (correlation r  0.87, P  .001).59 Gadolinium-
based contrast agents are known to distribute into the
extra-cellular fluid space and a greater degree of enhance-
ment in the vessel wall may be due to (1) increased wash-in
of gadolinium-based contrast agent (increased permeabil-
ity), (2) increased volume of distribution (increased extra-
cellular volume), (3) decreased washout.60
MR imaging can detect an unstable or disrupted fi-
brous cap with a sensitivity of 81-100% and a specificity of
80-90%.56,61,62 An unstable fibrous cap may be defined as
(1) interruptions or irregularities in the juxtaluminal area;
(2) absence of intimal tissue between the lumen and deeper
structures; or (3) focal contour abnormalities of the luminal
surface.62 In a small study (n  9), 5 subjects underwent
carotid endarterectomy and subsequent histologic exami-
nation. Gadolinium-enhanced images helped discriminate
fibrous cap from lipid core.60 Cai, et al, noted that the
degree of enhancement of the fibrous cap varied depending
on its composition. A fibrous cap with loose matrix, neo-
vasculature and inflammatory cell infiltrates was associated
with stronger enhancement compared with fibrous caps
predominantly composed of organized, dense collagen.59
This is consistent with the belief that greater enhancement
is seen with increased permeability and increased volume of
distribution within the cap.
Overall, MR imaging can detect plaque calcification with a
sensitivity of 76-98% and a specificity of 86-98%.55,56,58 Most
studies routinely decalcified their tissues in the histologic pro-
cessing, but this can be a source for error. Nevertheless,Saam, et al, found an underestimation by MRI of the
calcification as percentage of the vessel wall (5.0% by MRI,
9.4% by histology; P  .001).55 They suggested that calci-
fication shrinks less than other components during histo-
logic processing. Another possible explanation could be
that MRI underestimates areas with hypointense signals
because of signal averaging of voxels that only partially
contain calcification. The resolution of MRI and the inac-
curacy that can arise because of signal averaging is thought
to improve in the future with the development of better
hardware.55
An MRI has a clear advantage in plaque imaging: it
does not use ionizing radiation. An MRI has a moderate to
good ability to detect a number of plaque components.
Despite this, it is challenging to distinguish different intra-
plaque tissues from each other. For example, both calcifi-
cation and chronic hemorrhage produce hypointense sig-
nals in four separate contrast weightings. Differentiation
can only be made by very meticulous examination of the
borders of the hypointense signal to detect specific border
irregularities, which are characteristic for both plaque com-
ponents.63 Another drawback of MRI is the high percent-
age (8-28%) of failed tests because of poor image quality,
which is mainly due to motion artifacts. Finally, the use of
gadolinium-based contrast agents was considered harmless,
but recent reports describe an incidence of nephrogenic
systemic fibrosis in up to 3% of the patients with renal
dysfunction who receive gadolinium-based contrast during
MRI.64
In conclusion, the use of MRI to create images of
Fig 3. Fused PET-CT images of a 50-70% symptomatic stenosis
on the left side. Gray scale median of the plaque was 10 indicating
the existence of an atheromatous non-calcified plaque with high
risk for thromboembolism. No FDG uptake was noted at the level
of the asymptomatic stenosis on the contralateral side.vulnerable plaques is promising. However, scan time, im-
med t
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different tissues are all issues that need to be improved.
Additionally, it is anticipated that by the development of
new MR contrast agents for molecular imaging, like mag-
neto-nanoparticles, the accuracy of MR in detecting the
vulnerable plaque will improve.
NEW DEVELOPMENTS
The above-mentioned imaging modalities are used for
anatomic imaging; they can identify several morphological
features of the vulnerable plaque, but provide little or no
information regarding cellular and molecular mechanisms.
Cellular and molecular mechanisms can be measured by
systemic markers. Inflammation is an important part of
atherosclerosis and serum markers such as high sensitivity
C-reactive protein (hsCRP) are important independent risk
factors for future cardiovascular events.65 However, these
markers resemble the entire cardiovascular burden of a
patient and do not give information on specific plaques at
risk for rupture. New techniques are currently being devel-
oped to obtain images of molecular processes within spe-
cific plaques, techniques that try to image the morpholog-
ical properties of the plaque with new methods also
Fig 4. Ex-vivo near-infrared fluorescence imaging of in
endarterectomy. Specimens were analyzed with a pat
connected to a light-tight black chamber. Strongest autoflu
largest accumulation of MMPSense, a protease activatable
(MMPSense 680, VisEn Medical Inc, Woburn, Mass), seedenoted as functional molecular imaging.Optical coherence tomography (OCT). An OCT is
analogous to IVUS; while IVUS measures sound waves,
OCT measures the intensity of reflected infrared light. The
major advantage of OCT is the spatial resolution, which is
approximately 10 times higher than that of an ultrasound
scan.66 However, the major drawback to this invasive tech-
nique is the necessity to temporarily displace the blood
volume with saline, because blood significantly attenuates
OCT images. Another limitation of this technique is the
small penetration depth (1-2 mm), which is not enough to
obtain an image of the entire vessel wall.67,68 Therefore,
clinical use is not anticipated.
Thermography. Atherosclerosis is an inflammatory
process. Detection of the heat produced by activated mac-
rophages provides a metabolic functional characterization
of the atherosclerotic plaque. Temperature variations can
be measured with sensors fitted to catheters.69 A study
using carotid endarterectomy specimens and a needle ther-
mistor demonstrated that atherosclerotic plaques exhibit
thermal heterogeneity on their luminal surface.70 Catheter-
based measurements of coronary arteries showed an in-
creased difference in temperature and an increased hetero-
geneity in temperatures within the plaques in patients with
nd extraluminal sides of resected specimen after carotid
highly sensitive cooled charge-coupled device camera
nce signals were found at dense lipid core sites, whereas the
escent agent that is activated by matrix metalloproteinases
o occur at shoulder regions of the plaque.tra- a
ented
oresce
fluorischemic heart disease compared with healthy subjects.
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the differences were greater when the disease was more
severe (stable angina vs unstable angina vs acute myocardial
infarction).71 This suggests that progressive disease alters
the metabolic state of the atherosclerotic plaque. However,
thermography is an invasive technique and less patient-
friendly. Its true value in clinical application and improved
selection of patients needs to be evaluated.
Positron emission tomography (PET) and single
photon emission computed tomography (SPECT).
Nuclear imaging modalities are capable of visualizing met-
abolic activity and molecular processes. PET has an advan-
tage over SPECT in having a 2-3 times better spatial
resolution.72 The spatial resolution for PET is approxi-
mately 5 mm and is only useful in larger arteries. The
restricted resolution can be partially counteracted by co-
registration of scintigraphic images with CT (SPECT-CT
and PET-CT hybrid camera systems) or MRI. If PET and
SPECT are to gain a position as a clinical instrument in the
search for the vulnerable plaque, specific tracers will be
needed to image components which play an important role
in the formation and progression of vulnerable plaques.
The most widely available tracer for analysis of plaque
inflammation is 18F-Fluorodeoxyglucose (FDG). FDG
is a glucose analogue that is taken up by glucose-using cells
that are metabolically active, and it is phosphorylated by
hexokinase. However, no further intracellular metaboliza-
tion takes place, which results in an accumulation of the
tracer intracellularly. FDG is known to accumulate in
Fig 5. Overlay color photography of human carotid end
using the IVIS Spectrum camera system (FOV 15, binn
excitation/emission 680/720, epi-illumination). Image
panel; autofluorescence, middle panel) and one hour a
expressed as radiance (ph/sec/cm2/sr) and depicted as
fused with the fluorescent data (with kind permission of J
Center Groningen, Groningen, The Netherlands).macrophage-rich areas of carotid plaques. Rudd, et al,demonstrated that atherosclerotic plaque inflammation can
be imaged with FDG-PET, and that symptomatic unstable
plaques accumulate more FDG than asymptomatic le-
sions.73 Other radiolabeled SPECT tracers are available for
imaging specific plaque vulnerability items, such as 99mTc-
labeled oxidized low-density lipoprotein (99mTc-LDL) ac-
cumulation and apoptosis (99mTc-annexin-V). Preopera-
tive FDG-PET imaging of 17 patients who underwent a
carotid endarterectomy showed a significant correlation
between the PET signal from the carotid plaques and the
macrophage staining from the corresponding histological
sections (r  0.70; P  .0001).74 Assessment of macro-
phages in the specimens was done by themethod previously
described by Jander, et al, in which macrophages (CD68)
and T cells (CD3) were immunocytochemically stained.
The staining was quantified by planimetry of immuno-
stained areas (CD68) or counting individual cells (CD3).75
In a study combining FDG-PETwith high resolutionMRI,
3 out of 12 patients had inflamed lesions on localizations
different from the stenotic internal carotid lesion targeted
for surgery.4 Because of the time interval (up to 163 days)
between the index clinical event and the imaging, in which
period the patients received antiplatelet and cholesterol-
lowering therapy, the initial symptomatic lesion could have
become less inflamed, which could have had an effect on
the degree of FGD uptake. Therefore, quantification of
inflammatory levels within plaques cannot provide conclu-
sive evidence of causality. FDG-PET has also been used to
quantify reduction in carotid plaque inflammation after
ctomy specimen and near-infrared fluorescence imaging
6, aquisition 1 second, f/stop 2, spectral unmixing at
re taken immediately after resection (visible light, left
cubation with MMPSense 680 (right panel). Data are
udocolor scale on the right. Visible light pictures were
es S. de Jong, Department of Surgery, University Medicalartere
ing 1
s we
fter in
a pse
ohannstatin pharmacotherapy76 (Fig 3).
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tively and qualitatively detects the chemical composition of
an atherosclerotic plaque. A near infrared spectrometer
emits light into a sample and measures the proportion of
light that is returned over a wide range of optical wave-
lengths. It is based on the fact that different substances
absorb and scatter NIR light to different degrees at various
wavelengths.77 Ex-vivo analysis of freeze-dried sections of
carotid endarterectomy specimen measured at room tem-
perature within 10 minutes of harvesting showed signifi-
cantly different absorption spectra between stable and vul-
nerable plaques.78 A catheter-based system has been
developed that demonstrated the ability to safely obtain
high-quality near infrared spectra in 6 patients with stable
angina. Additional studies are planned to validate the tech-
nique’s ability to identify lipid-rich coronary artery plaques
and ultimately link chemical characterization with subse-
quent occurrence of an acute coronary syndrome.77 No
FDA approval for clinical use of molecular imaging probes
has yet been gained. Another innovative and promising
technique relates to the use of NIR fluorescence imaging
(NIRF). This technique operates in the near infrared spec-
trum for imaging of molecular processes like atherosclero-
sis.79 By using so-called smart activatable probes such as
MMPSense (VisEn Medical Inc, Woburn, Mass) activated
by MMPs like MMP-2 and MMP-9, these optical contrast
agents can be visualized in-vivo in dedicated small animal
imaging camera systems or in endarterectomy specimen
from patients after ex-vivo incubation with MMPSense
(Figs 4 and 5). MMP-2 andMMP-9 are considered impor-
tant biomarkers in the formation of a vulnerable plaque.80
In-vivoNIRF studies in patients have to be awaited in order
to evaluate this new technique on its merits for an improved
selection of patients.
CONCLUSION
There is not yet any superior modality of atheroscle-
rotic plaque imaging for the selection of patients for CEA.
First, there is no single imaging modality that can produce
definitive information about the level of vulnerability of an
atherosclerotic plaque. Most imaging modalities can pro-
duce only partial morphological information. Second, all
imaging modalities have their own specific drawbacks; they
are invasive, use ionizing radiation, or nephrotoxic contrast
agents, have low patient tolerability, or simply provide little
information about plaque vulnerability. Established tech-
niques such as US and CT need to be improved, while
SPECT, PET, MRI, and the associated specific probes and
contrast agents for functional molecular imaging need to be
further developed on their clinical applicability. Combined
techniques like SPECT-CT, PET-CT, and fused PET-MRI
may be promising tools for the near future for non-invasive
clinical use. The exact role of NIRS andNIRF in the clinical
setting needs to be further explored. From all this, we are
optimistic that it will be possible to develop a better selec-
tion policy for carotid intervention.We thank Ralph Houston for reading the manuscript.AUTHOR CONTRIBUTIONS
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